NORADRENALINE MYLAN noradrenaline (norepinephrine) (as acid tartrate monohydrate) 4 mg/4 mL injection concentrated vial

Kraj: Australia

Język: angielski

Źródło: Department of Health (Therapeutic Goods Administration)

Składnik aktywny:

noradrenaline (norepinephrine) acid tartrate monohydrate, Quantity: 7.548 mg (Equivalent: noradrenaline (norepinephrine), Qty 4 mg)

Dostępny od:

MedTAS Pty Ltd

Forma farmaceutyczna:

Injection, concentrated

Skład:

Excipient Ingredients: sodium chloride; water for injections; sodium metabisulfite

Droga podania:

Intravenous

Sztuk w opakowaniu:

10 x 4 mL vials, 5 x 4 mL vials

Typ recepty:

(S4) Prescription Only Medicine

Wskazania:

For the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion and drug reactions).,As an adjunct in the treatment of cardiac arrest. To restore and maintain an adequate blood pressure,after an effective heartbeat and ventilation have been established by other means.

Podsumowanie produktu:

Visual Identification: A clear colorless or practically colorless liquid filled in an amber Type I glass vial with a grey bromobutyl coated rubber stopper and flip off aluminium seal.; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 15 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status autoryzacji:

Registered

Data autoryzacji:

2022-01-14